Drug Profile
Naminterol
Alternative Names: VAL 479Latest Information Update: 03 Mar 1997
Price :
$50
*
At a glance
- Originator Valeas
- Class Antiasthmatics; Bronchodilators; Small molecules; Transferases
- Mechanism of Action Beta 2 adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 03 Mar 1997 No-Development-Reported for Asthma in Italy (Inhalation)
- 10 Oct 1991 Phase-II clinical trials for Asthma in Italy (Inhalation)